Chromosome 1q21 abnormalities refine outcome prediction in patients with multiple myeloma - a meta-analysis of 2,596 trial patients | Haematologica
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma - ScienceDirect
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome | Blood Cancer Journal
Systems medicine dissection of chromosome 1q amplification reveals oncogenic regulatory circuits and informs targeted therapy in cancer | bioRxiv
Nicolas Thomas Iannozzi on LinkedIn: Gain and/or amplification of the 1q21 region (1q21+) is one of the most…
Cancers | Free Full-Text | Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma
Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value | Haematologica
Outcomes of patients with multiple myeloma harboring chromosome 1q gain/ amplification in the era of modern therapy | Annals of Hematology
Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value | Haematologica
Cells | Free Full-Text | Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets
Proposed model of high-risk multiple myeloma development in reference... | Download Scientific Diagram
An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome. - Abstract - Europe PMC
Frontiers | Chromosome 1q21 gain is an adverse prognostic factor for newly diagnosed multiple myeloma patients treated with bortezomib-based regimens
Prognostic Value of 1q21 Gain in Multiple Myeloma - ScienceDirect
![PDF] Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/021a0aec1b05c89b61b715a94f2a080ee380e896/5-Table1-1.png "PDF] Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma | Semantic Scholar")
PDF] Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma | Semantic Scholar
Genetic Predictors of Mortality in Multiple Myeloma | TACG
Multiple myeloma with 1q21 amplification is highly sensitive to MCL-1 targeting - ScienceDirect
Cancers | Free Full-Text | Gain/Amplification of Chromosome Arm 1q21 in Multiple Myeloma
Empire Genomics | Amplification of 1q21 Linked to Poor Outcomes of Daratumumab-Based Treatments in Multiple Myeloma
Gain of 1q21 Is an Unfavorable Genetic Prognostic Factor for Multiple Myeloma Patients Treated with High-Dose Chemotherapy - Biology of Blood and Marrow Transplantation
Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities - ScienceDirect
The numerous facets of 1q21+ in multiple myeloma: Pathogenesis, clinicopathological features, prognosis and clinical progress (R
